Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed May 22, 2015
Insider Transaction Report
Form 4
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2015-05-20$8.40/sh+712$5,981→ 19,098 total
4 · Bellerophon Therapeutics, Inc. · Filed May 22, 2015
Common Stock